SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $543,000 | +924.5% | 180,545 | +729.6% | 0.00% | – |
| Q1 2015 | $53,000 | -83.3% | 21,762 | -82.5% | 0.00% | – |
| Q4 2014 | $317,000 | +68.6% | 124,421 | +373.6% | 0.00% | – |
| Q3 2014 | $188,000 | +51.6% | 26,273 | +38.4% | 0.00% | – |
| Q2 2014 | $124,000 | -76.8% | 18,981 | -76.5% | 0.00% | -100.0% |
| Q1 2014 | $535,000 | +35.4% | 80,840 | -3.2% | 0.00% | – |
| Q4 2013 | $395,000 | +49.1% | 83,492 | +56.9% | 0.00% | – |
| Q3 2013 | $265,000 | -13.4% | 53,218 | -10.1% | 0.00% | – |
| Q2 2013 | $306,000 | +61.1% | 59,208 | +71.0% | 0.00% | – |
| Q1 2013 | $190,000 | – | 34,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |